Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Catalent Inc (NY: CTLT ) 55.37 +0.12 (+0.22%) Official Closing Price Updated: 4:10 PM EDT, May 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Catalent Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > Catalent, inc (CTLT) Q4 2021 Earnings Call Transcript August 30, 2021 CTLT earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Mid-Afternoon Market Update: Affirm Shares Jump Following News Of Amazon Partnership; Adtran Shares Drop August 30, 2021 Toward the end of trading Monday, the Dow traded up 0.02% to 35,462.17 while the NASDAQ rose 1.02% to 15,283.07. The S&P also rose, gaining 0.59% to 4,535.90. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities Mid-Day Market Update: Nasdaq Jumps Over 100 Points; Astra Space Shares Plunge August 30, 2021 Midway through trading Monday, the Dow traded up 0.10% to 35,490.10 while the NASDAQ rose 0.85% to 15,258.38. The S&P also rose, gaining 0.59% to 4,536.02. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities Mid-Morning Market Update: Markets Mixed; Catalent To Acquire Bettera August 30, 2021 Following the market opening Monday, the Dow traded down 0.13% to 35,408.32 while the NASDAQ rose 0.61% to 15,221.76. The S&P also rose, gaining 0.32% to 4,523.75. The U.S.... Via Benzinga Topics Stocks Exposures US Equities Catalent's Debt Overview August 25, 2021 Shares of Catalent (NYSE:CTLT) rose by 23.76% in the past three months. Before having a look at the importance of debt, let us look at how much debt Catalent has. Catalent... Via Benzinga Catalent: Q3 Earnings Insights May 04, 2021 Shares of Catalent (NYSE:CTLT) decreased 0.1% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 64.00% over the past... Via Benzinga Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety Catalent Makes Strategic Move For Consumer Health Business With Bettera Deal August 30, 2021 Catalent Inc (NYSE: CTLT) has reported Q4 sales of $1.19 billion, +25% Y/Y as reported, or 22% in constant currency, edging out analysts' average expectation... Via Benzinga A Peek Into The Markets: US Stock Futures Edge Higher After S&P 500, Nasdaq Hit Record Highs August 30, 2021 Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the S&P and the Nasdaq hit record closing highs in the previous session following... Via Benzinga Topics Stocks Exposures US Equities 5 Stocks To Watch For August 30, 2021 August 30, 2021 Some of the stocks that may grab investor focus today are: Wall Street expects Zoom Video Communications Inc (NASDAQ: ZM) to report quarterly earnings at $1.16 per share on... Via Benzinga Earnings Scheduled For August 30, 2021 August 30, 2021 Companies Reporting Before The Bell Catalent Inc (NYSE: CTLT) is expected to report quarterly earnings at $1.03 per share on revenue of $1.14 billion. Cloudera, Inc. (NYSE: CLDR... Via Benzinga The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO August 26, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration August 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga Topics Intellectual Property Exposures Intellectual Property A Look Into Catalent's Price Over Earnings August 25, 2021 In the current market session, Catalent Inc. (NYSE:CTLT) is trading at $126.21, after a 0.1% drop. However, over the past month, the stock went up by 8.33%, and in... Via Benzinga EMA Approves Additional Sites To Boost Output Capacity For mRNA-Based COVID-19 Vaccines August 25, 2021 European Medical Agency (EMA) has approved additional manufacturing sites for mRNA-based coronavirus vaccines developed by Pfizer Inc (NYSE: PFE) - ... Via Benzinga Exposures COVID-19 Unusual Options Activity Insight: Catalent August 16, 2021 On Monday, shares of Catalent (NYSE:CTLT) saw unusual options activity. After the option alert, the stock price moved up to $121.14. Sentiment: BEARISH Option Type: TRADE Trade... Via Benzinga 2 Stocks Insiders Are Buying July 29, 2021 When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... Via Benzinga Catalent Plans $100M Expansion Of Biologics Capabilities At Italian Vaccine Plant July 21, 2021 Catalent Inc (NYSE: CTLT) will begin the first phase of a planned $100 million expansion at its facility in Anagni, Italy, to add biologics drug substance manufacturing... Via Benzinga Moderna's COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested June 29, 2021 Moderna Inc (NASDAQ: MRNA) has announced new results from in vitro neutralization studies of sera from individuals vaccinated with its COVID-19 vaccine. The COVID-... Via Benzinga Exposures COVID-19 5 Top ETFs With Exposure To Biogen June 07, 2021 For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that... Via Benzinga Exposures Product Safety AstraZeneca Seeks Switching COVID-19 Vaccine Production to Catalent Plant: NYT June 03, 2021 AstraZeneca Plc (NASDAQ: AZN) is in talks with the U.S. government to shift production of its COVID-19 vaccine from a troubled Emergent BioSolutions Inc’s (... Via Benzinga Exposures COVID-19 FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic May 10, 2021 The FDA has published a roadmap for working through the backlog of facility inspections built up during the pandemic when it postponed all routine inspections in March... Via Benzinga Exposures Product Safety Catalent Buys Promethera's Cell Therapy Subsidiary To Scale-Up Plasmid DNA Efforts May 06, 2021 Catalent Inc (NYSE: CTLT) has been expanding rapidly in next-gen cell therapies, and now it has added another facility in Belgium as part of its plan to... Via Benzinga Catalent Inc (CTLT) Q3 2021 Earnings Call Transcript May 04, 2021 CTLT earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data May 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Moderna Tries To Boost COVID-19 Vaccine Supply Chain To Produce 3B Doses Annually April 29, 2021 Moderna Inc (NASDAQ: MRNA) plans to produce up to 3 billion doses in 2022, doubling capacity at contract sites in Switzerland and Spain run by Lonza Group... Via Benzinga Exposures COVID-19 Moderna Stock Near Breakout As Company Boosts Its Covid Vaccines Outlook April 29, 2021 Moderna boosted its forecast for Covid vaccine doses in 2021 and 2022, in a move early Thursday that could send Moderna stock into a breakout. Via Investor's Business Daily Exposures COVID-19 < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.